🇺🇸 FDA

Company profile · Sponsor

BICYCLE

BICYCLE THERAPEUTICS

BCYC · NYSE pharma CAMBRIDGE, X0, USA
Pipeline
8
Drugs
7
Patents
8

Quick answer

BICYCLE (BCYC) is a pharma company. headquartered in CAMBRIDGE, X0, USA. listed on NYSE. NovaPharmaNews links 8 pipeline programs, 7 drugs, and 8 patents to this profile..

Company facts

Ticker BCYC
Exchange NYSE
Company type pharma
Headquarters CAMBRIDGE, X0, USA
SEC CIK 0001761612

Pipeline (8)

Search pipeline →

  1. CARBOPLATIN, GEMCITABINE, PEMBROLIZUMAB, CISPLATIN, BT8009, AVELUMAB

    BICYCLE

    Locally advanced or metastatic urothelial cancer

    phase 3 small molecule active

    1 trial

  2. Zelenectide Pevedotin, BT8009, PEMBROLIZUMAB, AVELUMAB, CISPLATIN, CARBOPLATIN, GEMCITABINE

    BICYCLE

    Locally advanced or metastatic urothelial cancer

    phase 3 small molecule active

    1 trial

  3. BT1718

    BICYCLE

    Advanced Solid Tumours

    phase 2 small molecule completed

    1 trial

  4. BT8009, Zelenectide Pevedotin

    BICYCLE

    NECTIN4 Amplified Advanced Breast Cancer

    phase 2 small molecule active

    1 trial

  5. BT8009, Zelenectide Pevedotin, PEMBROLIZUMAB

    BICYCLE

    Nectin-4 Expressing Advanced Malignancies.

    phase 2 small molecule active

    1 trial

  6. NIVOLUMAB, BT5528

    BICYCLE

    Advanced Malignancies Associated with EphA2 Expression

    phase 2 small molecule active

    1 trial

  7. Zelenectide Pevedotin, BT8009

    BICYCLE

    Advanced or Metastatic Non-small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  8. buprenorphine/naloxone

    BICYCLE

    Opioid Use Disorder

    approved small molecule terminated

    1 trial

Drugs (7)

Search drugs →

  1. cimetidine

    CIMETIDINE

    ORAL approved

  2. cimetidine hydrochloride

    TAGAMET HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

    INJECTION approved

  3. fingolimod lauryl sulfate

    TASCENSO ODT

    ORAL approved

  4. piroxicam

    PIROXICAM

    ORAL approved

  5. quinidine gluconate

    QUINIDINE GLUCONATE

    INJECTION approved

  6. quinidine sulfate

    QUINIDINE SULFATE

    ORAL approved

  7. reserpine

    RESERPINE

    INJECTION approved

Patents (8)

Search patents →

  1. US 12378288

    Multimeric bicyclic peptide ligands

    Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12377155

    Bicyclic peptide ligands specific for PSMA

    Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12350343

    Bicyclic peptide ligands specific for MT1-MMP

    Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12318454

    Bicyclic peptide ligands specific for MT1-MMP

    Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12150998

    Bicyclic peptide ligands specific for P-selectin

    Expires Mon Nov 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12049520

    Bicyclic peptide ligands specific for CD137

    Expires Mon Jul 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11970553

    Heterotandem bicyclic peptide complex

    Expires Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11970555

    Bicyclic peptide ligands specific for transferrin receptor 1 (TfR1)

    Expires Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is BICYCLE?

BICYCLE (BCYC) is a pharma company. headquartered in CAMBRIDGE, X0, USA. listed on NYSE. NovaPharmaNews links 8 pipeline programs, 7 drugs, and 8 patents to this profile..

What pipeline programs does BICYCLE sponsor?

We track 8 ClinicalTrials.gov-linked programs for BICYCLE, including CARBOPLATIN, GEMCITABINE, PEMBROLIZUMAB, CISPLATIN, BT8009, AVELUMAB and 7 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does BICYCLE company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.